Joanna Barankiewicz

14 Indiry Gandhi Str
Warsaw, MZ 02776, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Natural history of large adrenal tumors.

Natural history of large adrenal tumors.

Journal: Frontiers in endocrinology

Published: December 23, 2025

Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group.

Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group.

Journal: Annals of hematology

Published: September 20, 2025

Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors.

Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors.

Journal: International journal of molecular sciences

Published: October 05, 2024

CD71+ erythroid cells promote multiple myeloma progression and impair anti-bacterial immune response.

CD71+ erythroid cells promote multiple myeloma progression and impair anti-bacterial immune response.

Journal: British journal of haematology

Published: September 04, 2024

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

Journal: Oncoimmunology

Published: June 07, 2024

Potassium/sodium cation carriers robustly upregulate CD20 antigen by targeting MYC, and synergize with anti- CD20 immunotherapies to eliminate malignant B cells.

Potassium/sodium cation carriers robustly upregulate CD20 antigen by targeting MYC, and synergize with anti- CD20 immunotherapies to eliminate malignant B cells.

Journal: Haematologica

Published: May 13, 2024

CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma.

CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma.

Journal: Cancers

Published: August 30, 2022

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity.

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity.

Journal: Scientific reports

Published: August 05, 2022

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.

Journal: Clinical and experimental medicine

Published: June 20, 2022

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing.

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing.

Journal: Biomedicines

Published: June 11, 2022

Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia-A Multicenter Report by the Polish Lymphoma Research Group.

Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia-A Multicenter Report by the Polish Lymphoma Research Group.

Journal: Journal of clinical medicine

Published: May 31, 2022

SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution.

SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution.

Journal: Chemotherapy

Published: March 14, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026